名称: 色瑞替尼 英文名: Ceritinib CAS号: 1032900-25-6 产品描述:
:
色瑞替尼
中文别名:
5-氯-N2-(2-异丙氧基-5-甲基-4-(哌啶-4-基)苯基)-N4-(2-(异丙基磺酰基)苯基)嘧啶-2,4-二胺
英文名称:
Ceritinib
英文别名:
CS-1406;
LDK378;
5-chloro-N2-(2-isopropoxy-5-methyl-4-piperidin-4-ylphenyl)-N4-[2-(isopropylsulfonyl)phenyl]-pyrimidine-2,4-diamine;
Ceritinib (LDK378);
5-chloro-2-N-(5-methyl-4-piperidin-4-yl-2-propan-2-yloxyphenyl)-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine;
查看更多英文别名
CAS号:
1032900-25-6
分子式:
C28H36ClN5O3S
分子量:
558.13500
精确质量:
557.22300
Ceritinib (INN, trade name Zykadia) is a drug for the treatment of a specific type of lung cancer. It is an anaplastic lymphoma kinase (ALK) inhibitor. It was developed by Novartis. It was approved in April 2014 by the Food and Drug Administration for the treatment of ALK-positive metastatic non-small cell lung cancer (NSCLC) in patients that failed treatment with crizotinib. It is a more effective, but more toxic, alternative to traditional platinum-based chemotherapies. Ceritinib was found at physiological concentrations to inhibit ALK, insulin-like growth factor 1 receptor (IGF-1R), and ROS1
武汉药肽科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!